an additional incentive by Pfizer to participate in the trial could be to receive updates of the medical condition of the trial patients a bit quicker then is received by shareholders in IMU.
And such information would be very valuable if they wanted to make a decision to buy (sell) shares in the IMU.
there would be obvious limitations imposed by government regulations but there may be ways their smart lawyers have found to circumvent these.
just some wild speculation. Feel free to ignore my ignorance.
Ann: Results of Meeting, page-135
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.001(1.43%) |
Mkt cap ! $519.7M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.9¢ | $779.7K | 11.17M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2214164 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.1¢ | 1588020 | 12 |
View Market Depth
| Last trade - 16.10pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
0.001 ( 0.28 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.1¢ | 6.9¢ | 5174828 | ||
| Last updated 15.59pm 27/05/2024 ? | |||||
| IMU (ASX) Chart |